15 results on '"Pagan, F."'
Search Results
2. Impact of injection guidance techniques on the efficacy and safety of incobotulinumtoxinA for sialorrhea
3. Placebo-controlled, randomized, double-blind study of incobotulinumtoxinA for sialorrhea
4. Attainment of physiologic salivary flow rate with long-term incobotulinumtoxinA treatment for sialorrhea in Parkinson’s disease and other neurologic conditions
5. Long-term incobotulinumtoxinA treatment for chronic sialorrhea: efficacy and safety over 64 weeks
6. Efficacy of incobotulinumtoxinA in subjects with sialorrhea, assessed using the modified Radboud Oral Motor inventory for Parkinson’s disease (mROMP)
7. Cardiac dysautonomia in Parkinson's Disease
8. Attainment of physiologic salivary flow rate with long-term incobotulinumtoxinA treatment for sialorrhea in Parkinson's disease and other neurologic conditions
9. Current ICD-10-CM coding does not adequately reflect Parkinson's disease with motor complications
10. Nilotinib is reasonably safe and may halt the disease progression in moderately severe Parkinson's disease patients
11. A novel small molecule tyrosine kinase inhibitor (GUtinib) preferentially targets discoidin domain receptors and reduces toxic proteins in neurodegeneration
12. Duration of rimabotulinumtoxinB action in the treatment of adult sialorrhea
13. Nilotinib alters microRNAs that regulate specific autophagy and ubiquitination genes in the CSF of individuals with Parkinson's disease
14. Nilotinib increases brain dopamine and lowers CSF tau and oligomeric alpha-Synuclein in Parkinson's disease
15. P2.199 The national deep brain stimulation brain tissue network (DBS-BTN): preliminary results
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.